What is a RTP criterion for tinea corporis?

What is a RTP criterion for tinea corporis?

• A. RTP can occur immediately after starting topical treatment
• B. Lesions do not need to be covered during RTP
• C. Systemic antifungal therapy must be completed for 7 days
• D. Athletes must have used the topical fungicide for at least 72 hours and lesions adequately covered with a gas-permeable membrane

Answer: (D)

Return to play for tinea corporis hinges on controlling the infection and preventing its spread. The best criterion is that the athlete has used a topical antifungal for at least 72 hours and that the lesions are adequately covered with a gas-permeable membrane. The 72-hour period shows the antifungal has had time to reduce fungal load, while covering the lesions with a breathable barrier minimizes contact and environmental contamination during activity. This keeps players safe and protects teammates, without requiring systemic therapy. Starting treatment immediately after beginning therapy is not enough on its own, because contagiousness may still be present until the antifungal has had time to work. The criterion does require covering the lesions; leaving them exposed increases the risk of transmission. Completing systemic antifungal therapy for seven days is not a standard RTP requirement for this condition, as many cases are managed with topical therapy and local containment rather than systemic treatment.

Return to play for tinea corporis hinges on controlling the infection and preventing its spread. The best criterion is that the athlete has used a topical antifungal for at least 72 hours and that the lesions are adequately covered with a gas-permeable membrane. The 72-hour period shows the antifungal has had time to reduce fungal load, while covering the lesions with a breathable barrier minimizes contact and environmental contamination during activity. This keeps players safe and protects teammates, without requiring systemic therapy.

Starting treatment immediately after beginning therapy is not enough on its own, because contagiousness may still be present until the antifungal has had time to work. The criterion does require covering the lesions; leaving them exposed increases the risk of transmission. Completing systemic antifungal therapy for seven days is not a standard RTP requirement for this condition, as many cases are managed with topical therapy and local containment rather than systemic treatment.